Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy
MDR-TB numbers could keep growing despite improved treatment
Switching from efavirenz to lopinavir/ritonavir has no meaningful impact on neurological function, says UK study
Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies
